Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584753 · ClinicalTrials.gov registry record · Phase 1
Molecular Imaging of Breast Cancer With Breast PET/CT
A Phase 1 study, sponsored by University of California, Davis.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT00584753 is a Phase 1 study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 4 participants.
The verdict
NCT00584753, a Phase 1 study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study is a feasibility study to determine if a combined breast PET/CT scanner can image malignant functional activity while determining anatomical structure in the same clinical setting for patients with breast cancer. End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device. The secondary purpose of this study is to explore protocol parameters with a view to optimizing imaging performance whilst minimizing patient discomfort. Imaging results will be compared to histological samples to determine ground truth.
Interventions
- RADIATION Positron emission tomography and computed tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00584753
The ClinicalTrials.gov registry entry for NCT00584753 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Positron emission tomography and computed tomography is the first listed.
NCT00584753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00584753 about?
NCT00584753 is a clinical study titled "Molecular Imaging of Breast Cancer With Breast PET/CT". This study is a feasibility study to determine if a combined breast PET/CT scanner can image malignant functional activity while determining anatomical structure in the same clinical setting for patients with breast cancer. End-points of this study are whether women will accept the imaging position ...
What is the current status of trial NCT00584753?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2007-04. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00584753?
The interventions under investigation include: Positron emission tomography and computed tomography (RADIATION).
Who is sponsoring clinical trial NCT00584753?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.